ÂÜÀòÂÒÂ×

Kirk Christoffersen has a diverse work experience spanning over several industries. Kirk is currently the SVP and Chief Business Officer at FibroGen, Inc. since February 2022, previously serving as the VP and Chief Business Officer from November 2020 to February 2022. Prior to their current role, Kirk was the Chief Business Officer at Arch Oncology from May 2019 to September 2020. Kirk also held the position of SVP Corporate and Business Development at Compugen Ltd. from December 2016 to May 2019. Before that, Kirk served as the President of Apollo BioConsulting from September 2015 to December 2016. Kirk was also associated with GlobeImmune, Inc. as the Vice President Corporate Development - Corporate Officer from August 2013 to August 2015, and earlier as the Senior Director Corporate Development from November 2004 to August 2013. Additionally, Kirk has experience working at OSI Pharmaceuticals, Inc. as a Brand Leader, Marketing from August 2002 to October 2004 and as an Associate Director of Commercial Planning from January 2001 to August 2002. Kirk has also worked at Gilead Sciences in various positions, including Associate Director and Senior Manager in Corporate Development. Kirk started their career in the ski industry, starting as a Ski Patroller at Vail Mountain from August 1990 to August 1994 and later becoming the Ski Patrol Supervisor at Keystone Mountain from August 1994 to December 1997. Kirk also worked as a Business Development Consultant at Ribozyme Pharmaceuticals in 1996.

Kirk Christoffersen completed their Bachelor of General Studies (BGS) degree in Liberal Arts from the University of Michigan, attending from 1986 to 1990. In 1991, they pursued higher education at the University of Denver - Daniels College of Business, where they obtained their Master of Business Administration (MBA) degree. The field of study for their MBA degree is not specified.